Please login to the form below

Not currently logged in
Email:
Password:

Arix Biosciences

This page shows the latest Arix Biosciences news and features for those working in and with pharma, biotech and healthcare.

Blood disorder specialists Imara raises $63m

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech. US biotech Imara has just closed a $63m series B financing round to further develop therapeutics for the treatment of blood disorders. ... In return, Arix owns 10% of the company and Investment Director

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Roche CEO and chairman joins Arix Bioscience Former Roche CEO and chairman joins Arix Bioscience

    Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature. ... His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics